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Abstract
As a signaling molecule and an inhibitor of histone deacetylases (HDACs), butyrate exerts its impact on a broad range of
biological processes, such as apoptosis and cell proliferation, in addition to its critical role in energy metabolism in
ruminants. This study examined the effect of butyrate on alternative splicing in bovine epithelial cells using RNA-seq
technology. Junction reads account for 11.28 and 12.32% of total mapped reads between the butyrate-treated (BT) and
control (CT) groups. 201,326 potential splicing junctions detected were supported by $3 junction reads. Approximately
94% of these junctions conformed to the consensus sequence (GT/AG) while ,3% were GC/AG junctions. No AT/AC
junctions were observed. A total of 2,834 exon skipping events, supported by a minimum of 3 junction reads, were
detected. At least 7 genes, their mRNA expression significantly affected by butyrate, also had exon skipping events
differentially regulated by butyrate. Furthermore, COL5A3, which was induced 310-fold by butyrate (FDR ,0.001) at the
gene level, had a significantly higher number of junction reads mapped to Exon#8 (Donor) and Exon#11 (Acceptor) in BT.
This event had the potential to result in the formation of a COL5A3 mRNA isoform with 2 of the 69 exons missing. In
addition, 216 differentially expressed transcript isoforms regulated by butyrate were detected. For example, Isoform 1 of
ORC1 was strongly repressed by butyrate while Isoform 2 remained unchanged. Butyrate physically binds to and inhibits all
zinc-dependent HDACs except HDAC6 and HDAC10. Our results provided evidence that butyrate also regulated deacetylase
activities of classical HDACs via its transcriptional control. Moreover, thirteen gene fusion events differentially affected by
butyrate were identified. Our results provided a snapshot into complex transcriptome dynamics regulated by butyrate,
which will facilitate our understanding of the biological effects of butyrate and other HDAC inhibitors.
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Introduction
Alternative splicing (AS) is an important driving force behind
vast protein diversity and the evolution of phenotypic complex-
ity in mammals. AS generates various protein isoforms from
single genes with different biological properties [1] and plays a
critical role in development and disease [2–4]. Furthermore, AS
is under strict regulatory control, including an accurate
recognition of the splice junction that defines intron and exon
boundary [5]. AS is mediated by elaborate molecular machin-
ery, the spliceosome, which consists of at least 5 small nuclear
RNAs (snRNAs) and over 100 accessory proteins [6]. Mutations
in the core element of the spliceosome cause disease [7]. Up to
94% of human genes are estimated to undergo AS [4]; hence,
aberrant AS is frequently associated with numerous human
diseases [1]. Therefore, splicing modulation has been touted as
a therapeutic means for treating genetic diseases caused by
splicing mutations [8].
Butyrate is a preferred substrate for gut epithelial cells. In
ruminants, butyrate contributes to 70% of energy metabolism.
In monogastric species, butyrate also plays an important role in
energy metabolism in the hindgut [9]. Moreover, butyrate acts
as a histone deacetylase inhibitor and can induce apoptosis and
inhibit cell proliferation in vitro [10]. As a signaling molecule,
butyrate induces a profound change in gene expression and
results in a significant change in transcript abundance of ,50%
genes transcribed in the transcriptome of epithelial cells [11].
The effect of butyrate on growth rate of ovarian carcinoma cells
in vitro is associated with a significant decrease of proto-
oncogene MYC. Down-regulation of MYC is accomplished at
least partially by accelerated MYC mRNA degradation and by
inhibiting splicing [12]. Furthermore, butyrate is known to have
an impact on AS of vascular endothelial growth factor (VEGF)
gene [13]. Butyrate significantly increases the expression levels
of both mRNA and protein of transcript variants that are anti-
angiogenic in human lung endothelial cells while the pro-
angiogenic isoform is not detectable [13]. However, the effect of
butyrate on AS has not been systematically investigated in
cattle. In this study, we presented evidence that butyrate can
influence AS using high-throughput transcriptome technology
and bioinformatics.
PLoS ONE | www.plosone.org 1 June 2012 | Volume 7 | Issue 6 | e39182Results
1. Splice Junction Inference
The total number of reads mapped to the bovine genome
(UMD3.1) using the Genomic Short-read Nucleotide Alignment
Program (GSNAP) [14] were 52.25 and 47.73 million for the
butyrate-treated (BT) and control (CT) groups, respectively
(Table 1). For the sake of simplicity, only reads uniquely mapped
to the genome (i.e., hitting only one locus) were counted. Among
them, junction reads–those spanning exon-exon junctions with at
least 8 bp of overhangs in each exon–accounted for 11.28 and
12.32% for the butyrate and control groups, respectively
(P,0.001). These junction coverage results were in agreement
with a published report [15], which shows 10–16% reads
containing splice junctions in breast tumor samples. A total of
799,589 potential splicing junction sites were detected. Of them,
201,326 splice junction sites were supported by a minimum of 3
junction reads (mean; N=8). Approximately 94% of all splicing
sites conformed to the consensus sequence, GT/AG while ,3% of
junction sites belonged to the most common non-consensus splice
junction GC/AG. The percentage of GC/AG junction observed
in bovine epithelial cells was higher than that observed in humans
and other species [16] where the GT-GC conversation represents
only a small fraction at the donor sites (,1%). No AT/AC splice
junction sites were observed in the bovine epithelial cell in this
study (Table 1).
2. Exon Skipping
A total of 2,834 potentially consistent exon skipping events were
detected using GSNAP. A minimum of three junction reads (mean
across all eight samples tested) supported each of these events.
These junction reads were mapped to the same chromosome and
the same strand in the correct order within a close proximity of
20,000 bp as defined (consistent), as compared to other common
events, such as scrambles, where the two halves of junction reads
were mapped to the same chromosome and on the same strand
but in the wrong order. The 2,504 events were involved in 2,113
genes. Table 2 lists select exon skipping events with the difference
in mean junction read counts greater than 20.0 between butyrate-
treated and control groups. The gene expression level of all genes
involved in these exon skipping events was significantly regulated
by butyrate treatment at a stringent false discovery rate (FDR
,0.0001) [11]. For example, collagen, type V, alpha 3 (COL5A3)
was significantly up-regulated (,310 fold) by butyrate (P,0.0001
and FDR ,0.0001). The mean number of junction reads mapped
to exon #8 (donor) and exon#11 (acceptor) in butyrate-treated
cells was 16.00 (65.10, sd) while no junction reads spanning this
region (0.0060.00) were detected in control cells. This event had
the potential to result in the formation of an mRNA isoform with 2
of the COL5A3 69 exons missing (exon#9 and exon#10).
Quantitative RT-PCR confirmed this event (data not shown).
Similarly, Exon#2 of S100A1 gene may be skipped, supported by
multiple junction reads in BT, and the resultant new isoform was
also differentially regulated by butyrate (Table 2).
3. Gene Fusion Events Significantly Affected by Butyrate
Only consistent splice junctions–both halves of junction reads
mapped to the same chromosome strand in the correct order
within a default distance, 20,000 bp–were considered in this study.
Translocation (two halves mapped to different chromosomes),
inversion (two halves mapped to the same chromosome but on
opposite strands), scramble (on the same chromosome strand but
in an incorrect order) as well as the genomic deletion [17] were
excluded. The local gene fusion events or read-through in the
bovine epithelial cells were readily detected by GSNAP. Of these,
13 events were significantly affected by butyrate (P,0.05; Table 3).
The genes involved in these events were within the genomic
interval set by the default parameter, -w =20kb. As the table
shows, about half of the events are involved in the members of
gene families. For example, the gene fusion event involving keratin
8 (donor gene) and keratin 4 (acceptor gene) was supported by 236
and 165 junction reads for BT and CT groups, respectively
(P,0.0001). This event was verified independently using RT-
PCR. Similarly, a gene fusion between homeobox A6 (HOXA6)
and homeobox A5 (HOXA5) was supported by 3.47 and 7.19
junction reads for BT and CT, respectively (P,0.05). Interesting-
ly, this gene fusion also started from an alternative 59 splice
junction (donor site), changing the 39 boundary of the upstream
exon.
4. Differentially Expressed Isoforms Induced by Butyrate
Mixture-of-Isoforms algorithm (MISO), a probabilistic frame-
work that enables quantification of the expression level of
alternatively spliced genes and identification of differentially
regulated isoforms from RNA-Seq data [18], was used to detect
differentially expressed isoforms induced by butyrate in bovine
epithelial cells. In this study, MISO detected a total of 216
isoforms from 98 genes that were differentially regulated by
butyrate using a combined cutoff of DY .0.20 (i.e., the posterior
distribution over the change in Psi for each event) and Bayes factor
.10. The Bayes factor represents the weight of the evidence in the
data in favor of differential expression. For example, Bayes factor
=2 means that the isoform is two times more likely to be
differentially expressed. Of these events, 50 isoforms from 36 genes
were supported by at least 3 pair-wise comparisons (Table 4); 29 of
the 36 genes had two mRNA isoforms while the rest had at least 3
isoforms. The mRNA-level expression of defensin, beta 1 gene
(DEFB1) was not detected in control cells but significantly up-
regulated by butyrate (FDR ,0.001). This gene had two isoforms.
Isoform #1 had 3 exons and was not detectable in control cells but
barely detectable in butyrate-treated cells. However, Isoform#2
had 2 exons and was strongly induced by butyrate (Fig. 1).
Similarly, IL-18 (ENSBTAG00000000277) had 2 isoforms with
the same number of exons. These 2 isoforms differed in the exon
structure, nevertheless. Isoform#1 had a similar number of
assigned sequence reads while Isoform#2 had approximately 10
times more assigned reads in butyrate-treated cells (252.08630.51,
mean 6 sd) than in control cells (25.94613.69) (P,0.0001, Fig. 2).
Isoform #1 of origin recognition complex, subunit 1 (ORC1,
Table 1. Summary of junction reads.
Butyrate Control P value
Total mapped reads 52,250,74268,350,021 47,631,51165,010,005 NA
Junction reads % 11.2860.27 12.3260.19 0.0007
GT/AG Junction % 93.5360.83 93.8560.21 0.4868
GC/AG Junction % 3.0860.27 2.7660.12 0.0709
AT/AC Junction % 0.0060.00 0.0060.00 NA
Other Junctions % 3.3960.57 3.3960.12 0.9975
The mean length of input reads was 49 bp and two mismatches were allowed
by GSNAP. Reads hitting more than one locus in the genome were excluded.
Each exon-exon junction was supported by at least one junction (spliced) read
with a minimum of eight bases aligned to each exon. Read counts were
normalized. Numbers denote mean 6 sd (N=4).
doi:10.1371/journal.pone.0039182.t001
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168.26652.75 (6 sd) and 1239.75648.02 in butyrate and control
groups, respectively, and was strongly repressed by butyrate.
Isoform#2 of ORC1 remained unchanged. Histone deacetylase
10 (HDAC10) had 2 isoforms with the read count ratio between
dominant (ENSBTAT00000014602) and minor (EN-
SBTAT00000042583) isoforms greater than 150 in the control
cells. Similarly, the dominant isoform was significantly repressed
(P,0.00001), while the minor isoform was not affected by
butyrate. However, the expression of both isoforms of HDAC5
was strongly enhanced by butyrate treatment (data not shown).
For genes with $3 isoforms, one or 2 isoforms were often
differentially regulated by butyrate. As Figure 3 shows, the
expression level of Isoforms# 1 and 3 of aminoacylase 1gene
(ACY1) was unchanged but that of Isoform#2 was strongly
repressed by butyrate (Fig. 3). On the other hand, Isoform#2o f
coiled-coil domain containing 24 (CCDC24) was little changed in
response to butyrate treatment while Isoforms#1 and 3 were
significantly induced by butyrate (Fig. 4). Moreover, differential
expression of 6 selected transcript isoforms induced by butyrate,
including transcripts such as ENSBTAT00000009005 (LGALS9),
ENSBTAT00000010687 (CLSTN3), ENSBTAT00000012035
(MX1), ENSBTAT00000020401 (NASP), EN-
SBTAT00000036545 (GUK1), and ENSBTAT00000061158
(TACC2), were confirmed using RT-PCR.
Discussion
Butyrate is one of important short-chain fatty acids (SCFAs).
Produced in the rumen and hindgut by gut microorganisms,
butyrate is rapidly absorbed and utilized by the rumen and colon
epithelium, contributing to 75% of the total energy requirement in
ruminants and ,10% for humans [9,19]. Additionally, butyrate is
shown to reinforce intestinal barriers and modulate motility and
visceral sensitivity of the intestine [20]. As a signaling molecule,
butyrate induces apoptosis and inhibits cell proliferation, and
therefore, it has antitumorigenic properties. Butyrate is an
inhibitor of histone deacetylases (HDACs), one of three classes of
enzymes epigenetically modifying chromatin histones. Mounting
evidence suggests histone acetylation plays a major role in
controlling transcriptional activities of genes [21,22]. HDAC
inhibitors such as butyrate induce hyperacetylation of histones,
and therefore increase transcriptional activities [2]. This was
supported by our observation that the total number of genes
transcribed in butyrate-treated cells (mean 6 sd =19,3226155)
Table 2. Exon skipping events supported by multiple junction reads detected using GSNAP.
GENE_ID Gene Junction Donor Acceptor BT CT P value Exons skipped
ENSBTAG00000020548 ADC S0136341 –2:121444188 –2:121441559 10.2564.50 0.5060.58 0.0051 Exon#3
ENSBTAG00000001927 ATP6V1C2 S0315271 –11:86867132 –11:86863699 6.0064.55 0.2560.50 0.0456 Exon#11
ENSBTAG00000010179 COL5A3 S0120443 –7:15803726 –7:15802198 16.0065.10 0.0060.00 0.0008 Exon#9 & Exon#10
ENSBTAG00000011998 DUT S0460161 –10:62295493 –10:62292296 0.2560.50 11.0064.24 0.0024 Exon#2
ENSBTAG00000034680 FAM131C S0142521 +2:136612861 +2:136616956 7.2561.89 0.2560.50 0.0004 Exon#4 & Exoin#5
ENSBTAG00000018169 ITGB4 S0053350 –19:56477748 –19:56475490 11.0063.56 0.0060.00 0.0008 Exon#32 & Exon#33
ENSBTAG00000005163 S100A1 S0197907 –3:16816122 –3:16812906 6.5061.29 0.0060.00 0.0001 Exon#2
The number under Butyrate and Control denotes mean counts of junction reads (6 sd; N =4). Of exon skipping events detected, only those with the difference in the
mean read count between the 2 groups greater than 20.0 were listed. All genes in this table were significantly regulated by butyrate at the gene level at a strict false
discovery rate (FDR) ,0.001.
doi:10.1371/journal.pone.0039182.t002
Table 3. Gene fusion events significantly affected by butyrate in the bovine epithelial cells.
Donor Gene Acceptor Gene Exon involved (Donor) Exon involved (Acceptor) Butyrate (BT) Control (CT) P value
GNAS3 GNAS B Exon3 (5) E Exon6 (13) 311.39613.62 421.34617.64 0.0001
KRT8 KRT4 E Exon5 (12) B Exon 3 (9) 236.01613.21 165.2569.62 0.0001
MYL6B MYL6 B Exon 3 (7) E Exon 4 (7) 96.29612.20 134.74611.28 0.0036
EEF2 ZFR2 E Exon 13 (15) I Exon16-Exon17 (19) 23.3766.59 13.6963.52 0.0411
RBM12 CPNE1 B Exon 1 (3) E Exon 2 (16) 20.0764.39 12.0864.74 0.0483
RNF207 ICMT B Exon 16 (18) E Exon7 (7) 13.1964.10 7.9560.98 0.0474
HBZ HBA E Exon2 (3) B Exon3 (3) 11.3761.38 3.8661.88 0.0007
UBA3 TMF1 E Exon12 (18) I Exon8-Exon9 (17) 7.4261.42 3.8161.86 0.0217
SNORA3 RL27A M Exon 1 (1) E Exon4 (5) 5.5962.26 0.4360.50 0.0043
HHIPL2 AIDA I Exon3-Exon4 (9) I Exon6-Exon7 (10) 4.5162.38 1.4360.98 0.0500
HOXA6 HOXA5 I Exon2-Exon3 (3) B Exon2 (2) 3.4761.98 7.1962.20 0.0454
PPP6R2 NCAPH2 I Exon21-Exon22 (22) B Exon10 (21) 2.6360.66 12.7865.90 0.0142
ZNF865 ZNF524 I Exon2-Exon3 (3) M Exon1 (2) 1.9860.98 10.2862.18 0.0004
The number denotes normalized counts of junction reads that support the events (mean 6 sd; N=4).
doi:10.1371/journal.pone.0039182.t003
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Transcript_ID Exon Gene DY Bayes factor Butyrate Control P value
ENSBTAT00000055849 Exon1-10 CNST 0.23 1.01E+01 127.5616.3 288.0653.4 0.0012
ENSBTAT00000001328 Exon1-8 TCF7 0.24 1.24E+02 409.86117.5 740.4684.2 0.0038
ENSBTAT00000002887 Exon1-13 TRPC1 –0.53 2.91E+02 106.1669.6 287.6673.2 0.0115
ENSBTAT00000003925 Exon1-10 SESN1 0.30 2.44E+01 124.4647.5 43.6621.4 0.0211
ENSBTAT00000004789 Exon1-23 LPHN1 –0.57 1.98E+01 2077.46203.2 215.3677.1 0.0000
ENSBTAT00000004832 Exon1-22 XPO4 –0.21 1.95E+05 379.2634.2 1234.36117.6 0.0000
ENSBTAT00000043910 Exon1-19 CDC45 –0.41 3.70E+15 308.1628.4 485.6671.2 0.0036
ENSBTAT00000005623 Exon1-20 CDC45 –0.59 3.70E+15 186.0669.2 1677.8661.3 0.0000
ENSBTAT00000005904 Exon1-16 RGS3 0.20 1.31E+11 298.16104.9 88.7656.1 0.0125
ENSBTAT00000061169 Exon1-22 RGS3 0.80 1.31E+11 1348.56201.0 3809.66321.8 0.0000
ENSBTAT00000009025 Exon1-11 LGALS9 –0.56 3.53E+26 162.8620.7 28.366.1 0.0000
ENSBTAT00000009005 Exon1-10 LGALS9 –0.34 3.53E+26 263.3641.7 6.766.5 0.0000
ENSBTAT00000010525 Exon1-15 NCF2 0.24 1.29E+20 109.8618.7 605.2654.4 0.0000
ENSBTAT00000063771 Exon1-10 NCF2 0.76 1.29E+20 170.9618.7 447.6663.5 0.0002
ENSBTAT00000010689 Exon1-17 CLSTN3 0.44 1.12E+01 259.56138.2 16.5610.5 0.0127
ENSBTAT00000010687 Exon1-18 CLSTN3 0.56 1.12E+01 5215.36529.7 22.0610.6 0.0000
ENSBTAT00000037763 Exon1-4 C1orf144 –0.23 1.87E+02 436.5699.5 937.6680.6 0.0002
ENSBTAT00000013080 Exon1-10 NFYA –0.22 1.91E+01 1163.76138.5 562.46138.1 0.0008
ENSBTAT00000014028 Exon1-9 OCIAD1 0.35 2.54E+12 1036.8683.2 310.96107.1 0.0000
ENSBTAT00000046355 Exon1-9 OCIAD1 0.65 2.54E+12 1183.96107.7 2833.66232.6 0.0000
ENSBTAT00000014097 Exon1-12 NTRK2 0.64 2.59E+11 236.0613.4 8.864.2 0.0000
ENSBTAT00000014288 Exon1-16 TACC2 –0.56 1.00E+12 732.66123.3 2646.96179.7 0.0000
ENSBTAT00000061158 Exon1-22 TACC2 –0.34 1.00E+12 3954.16324.8 928.6677.7 0.0000
ENSBTAT00000052258 Exon1-14 NUMB –0.32 3.97E+29 396.66122.7 1202.96178.0 0.0003
ENSBTAT00000015508 Exon1-11 NUMB –0.68 3.97E+29 2654.46190.3 1423.06202.5 0.0001
ENSBTAT00000015772 Exon1-9 CCDC24 –0.25 1.20E+01 284.8636.1 22.2612.4 0.0000
ENSBTAT00000065091 Exon1-10 NDEL1 –0.33 3.60E+01 1039.26213.9 510.9661.5 0.0032
ENSBTAT00000016883 Exon1-9 ZDHHC16 –0.31 4.20E+02 258.2685.8 448.7659.0 0.0106
ENSBTAT00000017205 Exon1-20 PRUNE –0.55 2.81E+11 37.064.5 3.761.5 0.0000
ENSBTAT00000036664 Exon1-11 PRUNE –0.45 2.81E+11 76.4618.7 2.461.5 0.0002
ENSBTAT00000018490 Exon1-20 WDR52 0.43 1.39E+01 43.666.9 4.964.3 0.0001
ENSBTAT00000036545 Exon1-8 GUK1 0.15 8.20E+101 142.9646.8 771.1669.6 0.0000
ENSBTAT00000057267 Exon1-14 NASP –0.20 3.50E+70 730.0625.2 2444.76179.7 0.0000
ENSBTAT00000020401 Exon1-16 NASP –0.80 3.50E+70 766.3662.3 5612.56209.0 0.0000
ENSBTAT00000047968 Exon1-8 ZFPM1 –0.31 2.62E+02 595.1617.9 175.3641.1 0.0000
ENSBTAT00000066331 Exon1-7 EME2 –0.26 2.58E+01 19.1614.5 37.9612.7 0.0996
ENSBTAT00000056488 Exon1-3 NR2F2 –0.32 1.47E+01 24.8611.0 311.0664.1 0.0001
ENSBTAT00000023969 Exon1-3 NR2F2 –0.68 1.47E+01 194.4630.0 534.56110.8 0.0010
ENSBTAT00000024380 Exon1-7 PAOX 0.22 5.00E+05 644.9673.7 965.06103.5 0.0024
ENSBTAT00000026432 Exon1-12 SHC1 0.20 7.80E+106 2466.46195.7 1403.06208.4 0.0003
ENSBTAT00000040264 Exon1-13 SHC1 0.80 7.80E+106 4534.0617.6 7195.66384.6 0.0001
ENSBTAT00000027531 Exon1-11 LNX1 –0.58 1.25E+01 222.7617.6 24.0625.5 0.0000
ENSBTAT00000027603 Exon1-6 BACH2 0.45 1.96E+01 73.6617.1 13.563.3 0.0005
ENSBTAT00000043742 Exon1-13 MX1 0.31 7.46E+01 632.76160.7 159.4637.1 0.0012
ENSBTAT00000012035 Exon1-13 MX1 0.69 7.46E+01 5267.26970.5 298.5631.4 0.0001
ENSBTAT00000055077 Exon1-8 ACY1 0.22 1.00E+12 174.1617.6 1041.0686.8 0.0000
ENSBTAT00000045814 Exon1-14 ACY1 –0.16 1.04E+21 1820.66200.5 1443.56122.4 0.0184
ENSBTAT00000056825 Exon1-24 VAV1 0.70 5.67E+03 187.8636.9 11.865.8 0.0001
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(17,6266125) (P,0.00001). Transcriptional effects of butyrate
have been extensively investigated in various cell types, in both
in vitro and in vivo models [19,23–25]. Indeed, previous studies
have demonstrated that butyrate down-regulates genes controlling
cell proliferation in vitro, resulting in the inhibition of the
proliferation of epithelial cells [25,26]. Microarray results show
that butyrate has a profound effect in global gene expression,
including up-regulation of genes related to apoptosis and
differentiation [10,26]. Our recent transcriptome studies using
RNA-seq technology demonstrate that a 24-h butyrate treatment
significantly affects the transcript abundance of 11,408 of the
17,625 genes detected in the bovine epithelial cell, representing
,65% of the entire transcriptome [11,19]. However, these studies
focus on the transcription at a gene level. The effect of butyrate on
individual transcript isoforms and alternative splicing has been
systematically studied only recently in human cells [27]. In this
study, we examined the regulation of alternative splicing by
butyrate in bovine epithelial cells. Our results should facilitate a
better understanding of alternative splicing in the development of
epithelial cells-derived diseases.
Of four classes of histone deacetylases, butyrate inhibits
enzymatic activities of most HDACs in Class I, II, and IV, which
are zinc-dependent, except HDAC6 and HDAC10 [28]. Class III
Figure 1. Relative abundance of transcript isoforms of b-defensin 1 gene induced by butyrate in bovine epithelial cells. Reads per
kilobase of exon model per million mapped reads (RPKM) were displayed in the Y-axis for each sample tested. BT: butyrate-treated cells. C: untreated
control cells. Arcs with numbers represent junction reads. Diagrams below show the gene structures of two transcript isoforms. Left: the posterior
distribution with Y value.
doi:10.1371/journal.pone.0039182.g001
Table 4. Cont.
Transcript_ID Exon Gene DY Bayes factor Butyrate Control P value
ENSBTAT00000045636 Exon1-11 RANBP6 –0.20 1.00E+12 2395.36249.6 1939.16273.4 0.0488
ENSBTAT00000061564 Exon1-26 RANBP6 –0.80 1.00E+12 7688.96461.7 17216.66977.8 0.0000
The number under Butyrate and Control denotes mean counts of junction reads (6 sd; N =4). Exon denotes the exons in the transcript. Exon 1–17 indicates that this
transcript contains exon 1 to exon 17. DY denotes the difference in mean posterior distribution between two samples. Bayes factor represents the odds of differential
expression over no differential expression (mean of all significant comparisons). P values were calculated from junction reads between butyrate-treated and untreated
control groups using a modified t-test.
doi:10.1371/journal.pone.0039182.t004
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PLoS ONE | www.plosone.org 5 June 2012 | Volume 7 | Issue 6 | e39182Figure 2. Relative abundance of transcript isoforms of IL-18 gene induced by butyrate in bovine epithelial cells. Reads per kilobase of
exon model per million mapped reads (RPKM) were displayed in the Y-axis for each sample tested. BT: butyrate-treated cells. C: untreated control
cells. Arcs with numbers represent junction reads. Bold arcs show the junction supported by .10 junction reads. Diagrams below show the gene
structures of two transcript isoforms. Left: the posterior distribution with Y value.
doi:10.1371/journal.pone.0039182.g002
Figure 3. Relative abundance of transcript isoforms of aminoacylase 1 gene. Boxes denote the inter-quartile range between the 1
st and 3
rd
quartiles (25 and 75%, respectively). Blue: butyrate-treated cells; Red: untreated control cells. Y-axis: normalized read counts. ***indicates P,0.0001.
doi:10.1371/journal.pone.0039182.g003
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adenine dinucleotide for their catalytic activity [29]. SIRTs are
associated with chromtain regulation and affect genome stability in
yeast and may represent pivotal regulators of lifespan and aging
[30]. SIRTs catalyze two major biochemical reactions: deacetyla-
tion on lysine residues of target proteins by altering cellular
[NAD
+]/[NADH] ratios (SIRT1, SIRT2, SIRT3, SIRT5, and
SIRT7) and ADP-ribosylation (SIRT4 and SIRT6) [31]. In
neuronal cells, SIRT1, SIRT5, and SIRT6 are down-regulated,
whereas SIRT2, SIRT4, and SIRT7 up-regulated by butyrate
[32]. Our RNA-seq data suggest that butyrate regulated the
transcript abundance or gene expression of the majority of
HDACs (Table 5). Butyrate significantly increased the expression
of HDAC3, HDAC5, and HDAC11. On the other hand, the
expression level of HDACs7-10 was significantly down-regulated.
The mRNA levels of SIRT4 and SIRT6 were strongly up-
regulated while SIRT1 was significantly down-regulated by
butyrate (Table 5). However, the relative abundance of HDAC1,
HDAC2, HDAC4, and HDAC6 remained unchanged by
butyrate. In addition to its effect on the expression at the whole
gene level, butyrate selectively regulated the transcript abundance
of different mRNA isoforms. While the abundance of both short
and long isoforms of HDAC5 was significantly enhanced by
butyrate, only the long and dominant isoform of HDAC10 was
significantly down-regulated. Intriguingly, butyrate is unable to
inhibit the catalytic activity of HDAC10 [28]. Nevertheless,
butyrate may still exert its control on the deacetylase activity of
HDAC10 via transcriptional regulation at the mRNA level. Our
future work will focus on the biological relevance of various
HDAC isoforms induced by butyrate, especially various SIRTs
and their roles in cell senescence and aging.
Distant gene fusion events are well known in tumors, often
resulting from genomic abnormalities such as chromosomal
translocation. These events, such as BCL-ABL, lead to the
formation of a novel chimeric protein with different functions and
are one of the common mechanisms for oncogene activation [33].
Recently, a new type of fusion involving two adjacent genes in the
same orientation on the same chromosome has been described
[34,35]. Adjacent genes are normally transcripted independently.
However, a single transcript can be occasionally formed to include
at least part of one exon from each of two or more distinct genes
[36]. This phenomenon, Transcription Induced Chimeras (TICs)
[35] or Conjoined Genes (CGs) [36], is widespread in mammalian
genomes. It is estimated that at least 4%-5% of the tandem gene
pairs in the human genome can be transcripted into TICs.
Moreover, these TICs may possess novel functions because .70%
of them are conserved in other vertebrate genomes [36]. In this
Figure 4. Relative abundance of transcript isoforms of coiled-coil domain containing 24 (CCDC24) gene in bovine epithelial cells.
Boxes denote the inter-quartile range between the 1
st and 3
rd quartiles (25 and 75%, respectively). Blue: butyrate-treated cells; Red: untreated control
cells. Y-axis: normalized read counts. ***indicates P,0.0001.
doi:10.1371/journal.pone.0039182.g004
Table 5. The expression of histone deacetylases affected by
butyrate in the bovine epithelial cells.
Ensembl Gene ID Class Symbol Fold P_value FDR
ENSBTAG00000012698 I HDAC1 0.96 3.51E–01 0.4154
ENSBTAG00000011849 I HDAC2 1.04 4.07E–01 0.4718
ENSBTAG00000017360 I HDAC3 1.56 5.98E–13 0.0000
ENSBTAG00000017764 IIA HDAC4 0.98 8.09E–01 0.8479
ENSBTAG00000016254 IIA HDAC5 1.91 0.00E+00 0.0000
ENSBTAG00000013244 IIB HDAC6 1.02 7.45E–01 0.7934
ENSBTAG00000026819 IIA HDAC7 0.56 0.00E+00 0.0000
ENSBTAG00000046092 I HDAC8 0.38 0.00E+00 0.0000
ENSBTAG00000003808 IIA HDAC9 0.22 0.00E+00 0.0000
ENSBTAG00000011000 IIB HDAC10 0.50 0.00E+00 0.0000
ENSBTAG00000007208 IV HDAC11 22.63 0.00E+00 0.0000
ENSBTAG00000014023 III SIRT1 0.54 0.00E+00 0.0000
ENSBTAG00000001776 III SIRT2 1.13 9.96E–03 0.0152
ENSBTAG00000002044 III SIRT3 1.38 5.48E–04 0.0010
ENSBTAG00000021168 III SIRT4 2.03 8.18E–12 0.0000
ENSBTAG00000014904 III SIRT5 1.28 1.32E–06 0.0000
ENSBTAG00000019909 III SIRT6 1.96 0.00E+00 0.0000
ENSBTAG00000000039 III SIRT7 1.16 1.68E–02 0.0248
Fold changes are expressed as mean RPKM ratios of butyrate treated cells to
untreated control cells calculated using the Cuffdiff algorithm. The value in Fold
greater than 1.0 indicates a up-regulation by butyrate while the value smaller
than 1.0 suggests a down-regulation of the gene expression by butyrate.
doi:10.1371/journal.pone.0039182.t005
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junction reads. Intriguingly, these TICs were also differentially
regulated by butyrate in bovine epithelial cells. Approximately
46% of these fusion events were involved in the members of gene
families, which is much higher than 11% as previously reported
[36]. For example, TICs were formed between 2 homeobox genes,
HOXA6 and HOXA5 and between 2 keratin genes, KRT8 and
KRT4. In addition, the fusion between zinc finger proteins
ZNF865 and ZNF524 was also supported by multiple junction
reads, and a significantly higher number of reads was detected in
untreated control cells than in butyrate-treated cells. A similar
fusion event between ZNF649 and ZNF577 was identified in
prostate tumors [37]. A relatively higher percentage of TICs
between genes with related functions identified in this study should
be further examined. Most importantly, the functional significance
of these fusion events, especially their possible role in transcription
regulation, should be experimentally determined.
One advantage of GSNAP algorithm is its potential to identify
novel splice sites and therefore possibly novel transcript isoforms.
The algorithm relies on a maximum entropy model and uses
frequencies of nucleotides neighboring a donor and acceptor splice
site to discriminate between true and false splicing sites [14]. The
power of this approach was exemplified by a case study involving
the prohibitin gene (PHB). The prohibitin protein complex,
located in mitochondrial inner membrane, is formed by hetero-
meric binding of both PHB and PHB2 [38] and is involved in
transcription regulation and cell cycle progression by blocking the
G1/S transition of the cell cycle [39]. Prohibitin induces apoptosis
by interacting with the retinoblastoma protein as well as being
involved in the p53 pathway. Its 39 untranslated region (UTR) acts
as a novel class of non-coding regulatory RNAs. Additionally,
PHB expression is up-regulated in the retina in aging and diabetic
models and may serve as an oxidative marker [38]. A recent study
using thyroid tumor cell lines demonstrates that butyrate increases
PHB mRNA expression. Furthermore, butyrate as well as other
HDAC inhibitors, such as trichostatin A, affects PHB splicing [2],
leading to the over-expression of the longer isoform with 39 UTR.
Both inhibitors decrease the mRNA levels of the shorter isoform
but increase those of the longer isoform, which exerts a growth-
suppressive action. Our results showed that butyrate significantly
down-regulated the mRNA expression of both PHB and PHB2 in
the bovine epithelial cell (FDR ,0.0001). No known isoforms in
both genes have been annotated in cattle so far. Annotated PHB
and PHB2 genes have 7 and 10 exons, respectively. GSNAP
correctly identified all normally splicing exon-exon junctions.
Moreover, GSNAP detected novel splice sites. For example,
several junction reads detected in the untreated control cells
suggest a possible exon skipping event that may result in skipping
of Exon#2 in PHB2. Such reads were not detectable in the
butyrate-treated cells. In the PHB gene, significantly higher
numbers of junction reads in the control group than the butyrate-
treated group indicated that multiple alternative splicing events
involved Exon#1 and Exon#2 and the intron between them.
These events occurred in the 59 UTR and did not seem to alter its
primary protein structure. In humans, the 39 UTR of PHB is
attributed to its anti-tumorigenic and anti-proliferative properties
[40]. The biological implication of various splicing events in the 59
UTR of PHB genes in cattle is worthy of further investigation.
Materials and Methods
1. Treatments
The bovine epithelial cells used in this study were previously
described [11]. The culture and sodium butyrate treatment was
essentially the same as reported [26]. Briefly, cells were treated with
10 mM sodium butyrate for 24h. As a result of butyrate treatment,
cell cycle arrest was notable. The percentage of G1/G0 cells was
increased from ,41% in normal cell populations to 79% in
butyrate-treatedcellpopulations,inagoodagreementwithprevious
results [10]. Cells were then harvested and high-quality total RNA
(RNA Integrity number or RIN .9.0) was processed using an
Illumina TruSeqRNAsampleprep kitfollowingthemanufacturer’s
instruction (Illumina, San Diego, CA, USA). After quality control
procedures, individual RNA-seq libraries were then pooled based
on their respective sample-specific 6-bp adaptors and sequenced at
50bp/sequence read using an Illumina HiSeq 2000 sequencer as
described previously [41]. The mean number of sequence reads
generated per sample was 67,527,11168,330,388.58 (6 sd). A total
of eight replicates in two groups, butyrate treated (BT) and
untreated (control or CT; N =4 for each group), were used. Raw
sequence reads were deposited to the NCBI Sequence Read
Archive (accession# SRA051007.1).
2. Data Analysis and Bioinformatics
Raw sequence reads were first checked using our quality control
pipeline. Nucleotides of each raw read were scanned for low
quality and trimmed using SolexaQA [42]. Input reads were then
aligned to the bovine reference genome using GSNAP [14] with
default parameters. Two mismatches were tolerated (‘‘-m 20 flag).
The intron size was specified by ‘‘-w’’ =20,000 bp. Read counts,
including junction reads, were extracted from GSNAP –N flag
output files and further analyzed.
For differentially expressed isoform detection, Mixture-of-
Isoforms program (MISO v 0.4.1, released February 1, 2012)
[18] was used. Trimmed reads were first aligned to the bovine
genome (UMD3.1) with TopHat [43] using default parameters.
The TopHat SAM output files were converted into BAM files and
input into MISO with the GTF file from ENSEMBL bovine
genebuild release 65. Differentially expressed isoforms were
detected using the following filtering parameters: the sum of
inclusion and exclusion reads is greater than 10 ($1 inclusion read
and $1 exclusion read), DY greater than 0.20, and the Bayes
factor $10. In addition, each SAM output file from TopHat
alignment, along with the GTF file from ENSEMBL bovine
genebuild release v65, were used in the Cuffdiff program [44] in
the Cufflink package (v1.3.0) to test for differential expression at
the gene level, as described previously [19].
3. Quantitative RT-PCR
Ten selected alternative splicing events, including 2 exon-
skipping event, 2 gene fusion events, and 6 transcript isoforms,
were tested using real-time RT-PCR as described previously [45].
Briefly, the cDNA synthesis was performed using an iScript cDNA
Synthesis kit (Bio-Rad, Hercules, CA). Real-time RT-PCR analysis
was carried out with an iQ SYBR Green Supermix kit (Biorad)
using 200 nM of each primer and the 1
st-strand cDNA (100 ng of
the input total RNA equivalents) in a 25 ml reaction volume. The
amplification was carried out on an iCycler iQ
TM Real Time PCR
DetectionSystem (BioRad) with the followingprofile:95uC –60s;40
cycles of 94uC–15s, 60uC –30s, and 72uC –30s. A melting curve
analysis was performed for each primer pair. PCR products were
further analyzed on a high-sensitive DNA chip using an Agilent
Bioanalyzer 2100 (Agilent, Palo Alto, CA, USA) for product length.
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